Suffice it to Say, Pending Claims Are Irrelevant for Sufficiency16 Aug 2022Aleem AbdullaThe Federal Court of Appeal clarified in Pharmascience v. Bristol-Myers Squibb, 2022 FCA 142, that the specification of the issued patent, not...Read More
